Literature DB >> 7441417

Treatment of hyperammonemic coma caused by inborn errors of urea synthesis.

M L Batshaw, S W Brusilow.   

Abstract

The relative effectiveness of exchange transfusion, peritoneal dialysis, arginine, and sodium benzoate was evaluated during 44 episodes of hyperammonemic coma in 31 patients with congenital urea cycle enzymopathies. The overall survival rate was 56%. In 15 episodes treated with EXT the fall in ammonium was 19 +/- 24%, P > 0.05. In 30 episodes treated with PD, the fall in ammonium was 60 +/- 9%, P < 0.001. Ten times more nitrogen was removed as glutamine than as ammonium during dialysis, suggesting that the effectiveness of PD resides in the removal of glutamine, glutamate, and alanine as well as ammonium. Prior to therapy all patients had hypoargininemia (18 +/- 2 microM); they responded to arginine supplementation with a rise in plasma arginine concentration to normal. In patients with AL deficiency, arginine supplementation (4 mmol/kg/day) was associated with a fall in ammonium level from 917 +/- 62 to 103 +/- 18 microM within 24 hours. When sodium benzoate (250 mg/kg/day) was used during eight episodes of coma, six patients responded with a significant decrease in plasma ammonium.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441417     DOI: 10.1016/s0022-3476(80)80416-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

1.  Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency.

Authors:  M Tuchman; S M Mauer; R A Holzknecht; M L Summar; C L Vnencak-Jones
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  A Handheld, Colorimetric Optoelectronic Dynamics Analyzer for Measuring Total Ammonia of Biological Samples.

Authors:  Nai-Yuan Liu; Pinar Cay-Durgun; Tianmiao Lai; Mark Sprowls; Leslie Thomas; Mary Laura Lind; Erica Forzani
Journal:  IEEE J Transl Eng Health Med       Date:  2018-07-05       Impact factor: 3.316

3.  Improvement of hepatic encephalopathy by application of peritoneal dialysis in a patient with non-end-stage renal disease.

Authors:  C Pipili; A Polydorou; K Pantelias; P Korfiatis; F Nikolakopoulos; E Grapsa
Journal:  Perit Dial Int       Date:  2013 Mar-Apr       Impact factor: 1.756

4.  Stable isotopes in the diagnosis and treatment of inherited hyperammonemia.

Authors:  Nicholas Ah Mew; Marc Yudkoff; Mendel Tuchman
Journal:  J Pediatr Biochem       Date:  2014-01-01

5.  Biochemical markers and neuropsychological functioning in distal urea cycle disorders.

Authors:  Susan E Waisbren; David Cuthbertson; Peter Burgard; Amy Holbert; Robert McCarter; Stephen Cederbaum
Journal:  J Inherit Metab Dis       Date:  2018-02-08       Impact factor: 4.982

Review 6.  3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: review of 18 reported patients.

Authors:  K M Gibson; J Breuer; W L Nyhan
Journal:  Eur J Pediatr       Date:  1988-12       Impact factor: 3.183

7.  The early detection and management of inborn errors presenting acutely in the neonatal period.

Authors:  J V Leonard
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

8.  Potentiation of hyperammonemia by sodium benzoate in animals. A note of caution.

Authors:  J E O'Connor; M Ribelles; S Grisolia
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

9.  Carbamyl phosphate synthetase deficiency with lethal neonatal outcome.

Authors:  J Jaeken; H Devlieger; C Bachmann; J Van Aerde; L Corbeel; E Eggermont
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

10.  Peritoneal dialysis in neonates with inborn errors of metabolism: is it really out of date?

Authors:  Ivana Pela; Daniela Seracini; Maria Alice Donati; Giancarlo Lavoratti; Elisabetta Pasquini; Marco Materassi
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.